ICH STABILITY STANDARDS SHOULD NOT APPLY TO GENERICS, NAPM TELLS FDA IN LETTER; AGENCY's WILLIAMS BELIEVES NDA/ANDA SUPPLEMENT STANDARDS SHOULD BE THE SAME
Executive Summary
Manufacturing control standards developed by the International Conference on Harmonization for the approval of new molecular entities should not be applied to generic drugs, the National Association of Pharmaceutical Manufacturers asserts.